Herbal products have gained popularity over the past few decades. The reasons attributed to the rise in popularity are cheaper costs, easy availability, patient compliance and fewer side effects. However, liver toxicity following consumption of herbal remedies is on the increase. Thus, there is an urgent need to understand the mechanism of action of the herbal supplements on the liver. Occasionally, herbal supplements may also interact with conventional drugs. The present review focusses on a few herbs such as Aloe barbadensis, Atractylis gummifera, Centella asiatica, Mitragyna speciosa, Morinda citrifolia, Larea tridentata, Symphytum officinale, Teucrium chamaedrys and Xanthium strumarium, which are reported to cause hepatotoxicity in humans and animals. Prior knowledge on hepatotoxicity caused by herbs may be beneficial for clinicians and medical practitioners.
SchianoT. (1998) Liver injury from herbs and other botanical. Clinics in liver disease, 2, 607–630.
2.
KellyJP, KaufmanDW, KelleyK, RosenbergL, AndersonTE, MitchellAA. (2005) Recent trends in use of herbal and other natural products. Archives of Internal Medicine, 165, 281–286.
3.
NiggemannB, GruberC. (2003) Side-effects of complementary and alternative medicine. Allergy, 58, 707–716.
4.
ZimmermanHJ. (1999) Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver, 2° ed. Lippincott Williams & Wilkins, Philadelphia, 11–295.
5.
JonesAL. (1996) Anatomy of the normal liver. In Hepatology: a textbook of liver disease, 3rd ed. ZakimD, BoyerTD. (Eds). WB Saunders, Philadelphia, 3–32.
6.
MalarkeyDE, JohnsonK, RyanL, BoormanG, MaronpotRR. (2005) New insights into functional aspects of liver morphology. Toxicologic Pathology, 33, 27–34.
7.
PatelDK, PatelK, DhanabalSP. (2012) Phytochemical standardization of Aloe vera extract by HPTLC techniques. Journal of Acute Disease, 1, 47–50.
8.
VoglerBK, ErnstE. (1999) Aloe vera: a systematic review of its clinical effectiveness. British Journal of General Practice, 49, 823–828.
9.
RabeC, MuschA, SchumacherP, KruisW, HoffmannR. (2005) Acute hepatitis induced by an Aloe vera preparation: a case report. World Journal of Gastroenterology, 11, 303–304.
YangHN, KimDJ, KimYM, KimBH, SohnKM, ChoiMJ, ChoiYH. (2010) Aloe-induced toxic hepatitis. Journal of Korean Medical Science, 25, 492–495.
12.
LeeJ, LeeMS, NamKW. (2014) Acute toxic hepatitis caused by an Aloe vera preparation in a young patient: a case report with a literature review. Korean Journal of Gastroenterology, 64, 54–58.
13.
DanieleC, DahamnaS, FiruziO, SekfaliN, SasoL, MazzantiG. (2005) Atractylis gummifera L. poisoning: an ethnopharmacological review. Journal of Ethnopharmacology, 97, 175–181.
14.
StickelF, EgererG, SeitzHK. (2000) Hepatotoxicity of botanicals. Public Health Nutrition, 3, 113–124.
15.
HamoudaC, HedhiliA, Ben SalahN, ZhiouaM, AmamouM. (2004) A review of acute poisoning from Atractylis gummifera L. Veterinary and Human Toxicology, 46, 144–146.
16.
GeorgiouM, SianidouL, HatzisT, PapadatosJ, KoutselinisA. (1988) Hepatotoxicity due to Atractylis gummifera L. Clinical Toxicology, 26, 487–493.
17.
JahanR, HossainS, SerajS, NasrinD, KhatunZ, DasPR, IslamMT, AhmedI, RahmatullahM. (2012) Centella asiatica (L.) Urb: Ethnomedicinal uses and their scientific validations. American-Eurasian Journal of Sustainable Agriculture, 6, 261–270.
18.
JorgeOA, JorgeAD. (2005) Hepatotoxicity associated with the ingestion of Centella asiatica. Revista Espanola de Enfermedades Digestivas, 97, 115–124.
19.
JamesJT, DuberyIA. (2009) Pentacyclic triterpenoids from the medicinal herb, Centella asiatica L. Molecules, 14, 3922–3941.
20.
HashimP, SidekH, HelanMH, SaberyA, PalanisamyUD, IlhamM. (2011) Triterpene composition and bioactivities of Centella asiatica. Molecules, 16, 1310–1322.
21.
GurfinkelDM, ChowS, HurrenR, GrondaM, HendersonC, BerubeC, HedleyDW, SchimmerAD. (2006) Disruption of the endoplasmic reticulum and increases in cytoplasmic calcium are early events in cell death induced by the natural triterpenoid asiatic acid. Apoptosis, 11, 1463–1471.
22.
LeeYS, JinDQ, KwonEJ, ParkSH, LeeES, JeongTC, NamDH, HuhK, KimJA. (2002) Asiatic acid, a triterpene, induces apoptosis through intracellular Ca2+ release and enhanced expression of p53 in HepG2 human hepatoma cells. Cancer Letters, 186, 83–91.
23.
AntonyB, SanthakumariG, MerinaB, SheebaV, MukkadanJ. (2006) Hepatoprotective effect of Centella asiatica L. in carbon tetrachloride-induced liver injury in rats. Indian Journal of Pharmaceutical Sciences, 68, 772–776.
24.
PingaleSS. (2008) Evaluation of effect of Centella asiatica on CCL4 induced rat liver damage. Pharmacologyonline, 3, 537–543.
25.
TangLX, HeRH, YangG, TanJJ, ZhouL, MengXM, HuangXR, LanHY. (2012) Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro. PLoS One, 7, e31350.
26.
ArteagaS, Andrade-CettoA, CardenasR. (2005) Larrea tridentata (Creosote bush), an abundant plant of Mexican and US-American deserts and its metabolite nordihydroguaiaretic acid. Journal of Ethnopharmacology, 98, 231–239.
27.
KatzM, SaibilF. (1990) Herbal hepatitis: Subacute hepatic necrosis secondary to chaparral leaf. Journal of Clinical Gastroenterology, 12, 203–206.
28.
AldermanS, KailasS, GoldfarbS, SingaramC, MaloneDG. (1994) Cholestatic hepatitis after ingestion of chaparral leaf: confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy. Journal of Clinical Gastroenterology, 19, 242–247.
LambertJD, ZhaoD, MeyersRO, KuesterRK, TimmermannBN, DorrRT. (2002) Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse. Toxicon, 40, 1701–1708.
31.
UlbrichtC, CostaD, DaoJ, IsaacR, LeBlancYC, RhoadesJ, WindsorRC. (2013) An evidence-based systematic review of Kratom (Mitragyna speciosa) by the Natural Standard Research Collaboration. Journal of Dietary Supplement, 10, 152–170.
32.
TakayamaH. (2004) Chemistry and pharmacology of analgesic indole alkaloids from the Rubiaceous plant, Mitragyna speciosa. Chemical and Pharmaceutical Bulletin (Tokyo), 52, 916–928.
33.
HassanZ, MuzaimiM, NavaratnamV, YusoffNH, SuhaimiFW, VadiveluR, VicknasingamBK, AmatoD, von HörstenS, IsmailNI, JayabalanN, HazimAI, MansorSM, MüllerCP. (2013) From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neuroscience Biobehavioral Review, 37, 138–151.
34.
AhmadK, AzizZ. (2012) Mitragyna speciosa use in the northern states of Malaysia: a cross-sectional study. Journal of Ethnopharmacology, 141, 446–450.
35.
KappFG, MaurerHH, AuwärterV, WinkelmannM, Hermanns-ClausenM. (2011) Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa). Journal of Medical Toxicology, 7, 227–231.
36.
JansenKL, PrastCJ. (1988) Ethnopharmacology of kratom and the Mitragyna alkaloid. Journal of Ethnopharmacology, 23, 115–119.
37.
DormanC, WongM, KhanA. (2015) Cholestatic hepatitis from prolonged kratom use: A case report. Hepatology, 61, 1086–1087.
38.
HarizalSN, MansorSM, HasnanJ, TharakanJK, AbdullahJ. (2010) Acute toxicity study of the standardized methanolic extract of Mitragyna speciosa Korth in rodent. Journal of Ethnopharmacology, 131, 404–409.
39.
SakaranR, OthmanF, JantanI, ThentZC, DasS. (2014) Effect of subacute dose of Mitragyna speciosa Korth crude extract in female Sprague Dawley rats. Journal of Medical and Bioengineering, 39, 98–101.
40.
PawlusAD, KinghornDA. (2007) Review of the ethnobotany, chemistry, biological activity and safety of the botanical dietary supplement Morinda citrifolia (noni). Journal of Pharmacy and Pharmacology, 59, 1587–609.
41.
StadlbauerV, FickertP, LacknerC, SchmerlaibJ, KrisperP, TraunerMStauberRE. (2005) Hepatotoxicity of NONI juice: Report of two cases. World Journal of Gastroenterology, 11, 4758–4760.
42.
MillonigG, StadlmannS, VogelW. (2005) Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). European Journal of Gastroenterology and Hepatology, 17, 445–447.
43.
YuceB, GulbergV, DieboldJ, GerbesAL. (2006) Induced by Noni juice from Morinda citrifolia: A rare cause of hepatotoxicity or the tip of the iceberg?Digestion, 73, 167–170.
44.
Lopez-Cepero AndradaJM, Lerma CastillaS, Fernandez OlveraMD, Amaya VidalA. (2007) Hepatotoxicity caused by a Noni (Morinda citrifolia) preparation. Revista Espanola de Enfermedades Digestivas, 99, 179–181.
45.
StadlbauerV, WeissS, PayerF, StauberRE. (2008) Herbal does not all mean innocuous: the sixth case of hepatotoxicity associated with Morinda citrofolia (noni). American Journal of Gastroenterology, 103, 2406–2407.
46.
YuELSivagnanamM, EllisL, HuangJS. (2011) Acute hepatotoxicity after ingestion of Morinda citrifolia (Noni berry) juice in a 14-year-old boy. Journal of Pediatric Gastroenterology and Nutrition, 52, 222–224.
47.
MrzljakA, KosutaI, SkrticA, KanizajTF, VrhovacR. (2013) Drug-induced liver injury associated with Noni (Morinda citrifolia) juice and phenobarbital. Case Report in Gastroenterology, 7, 19–24.
48.
LiFK, LaiCK, PoonWT, ChanAY, ChanKW, Tse KC ChanTM, LaiKN. (2004) Aggravation of non-steroidal anti-inflammatory drug-induced hepatitis and acute renal failure by slimming drug containing anthraquinones. Nephrology Dialysis and Transplantation, 19, 1916–1917.
49.
WangMY, NowickiD, AndersonG, JensenJ, WestB. (2008) Liver protective effects of Morinda citrifolia (Noni.)Plant Foods for Human Nutrition, 63, 59–63.
50.
WestBJ, SuCX, JensenCJ. (2009) Hepatotoxicity and subchronic toxicity tests of Morinda citrifolia (noni) fruit. The Journal of Toxicology Science, 34, 581–585.
51.
WestBJ, WhiteLD, JensenCJ, PaluAK. (2009) A double-blind clinical safety. Study of Noni fruit juice. Pacific Health Dialog, 15, 21–32.
StickelF, SeitzHK. (2000) The efficacy and safety of comfrey. Public Health Nutrition, 4A, 501–508.
54.
WestonCF, CooperBT, DaviesJD, LevineDF. (1987) Veno-occlusive disease of the liver secondary to ingestion of comfrey. British Medical Journal, 295, 183.
55.
BachN, ThungSN, SchaffnerF. (1989) Comfrey herb tea-induced hepatic veno-occlusive disease. The American Journal of Medicine, 87, 97–99.
56.
YeongML, SwinburnB, KennedyM, NicholsonG. (1990) Hepatic veno-occlusive disease associated with comfrey ingestion. Journal of Gastroenterology and Hepatology, 5, 211–214.
57.
YeongML, ClarkSP, WaringJM, WilsonRD, WakefieldSJ. (1991) The effects of comfrey derived pyrrolizidine alkaloids on rat liver. Pathology, 23, 35–38.
58.
YeongML, WakefieldSJ, FordHC. (1993) Hepatocyte membrane injury and bleb formation following low dose comfrey toxicity in rats. International Journal of Experimental Pathology, 74, 211–217.
59.
BetzJM, EppleyRM, TaylorWC, AndrzejewskiD. (1994) Determination of pyrrolizidine alkaloids in commercial comfrey products (Symphytum sp.). Journal of Pharmaceutical Science, 83, 649–653.
60.
McLeanEK. (1970) The toxic actions of pyrrolizidine (Senecio) alkaloids. Pharmacological Reviews, 22, 429–483.
61.
SeeffLB. (2007) Herbal hepatotoxicity. Clinic in Liver Disease, 11, 577–596.
62.
CastotA, LarreyD. (1992) Hepatitis observed during a treatment with a drug or tea containing Wild Germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance. Gastroenterologie Clinique et Biologique, 16, 916–922.
63.
LarreyD, VialT, PauwelsA, CastotA, BiourM, DavidMMichelH. (1992) Hepatitis after germander (Teucrium chamaedrys) administration: Another instance of herbal medicine hepatotoxicity. Annals of Internal Medicine, 117, 129–132.
64.
Ben YahiaM, MavierP, MétreauJM, ZafraniES, FabreM, Gatineau-SaillantG, DhumeauxD, MallatA. (1993) Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases. Gastroenterology Clinique et Biologique, 17, 959–962.
65.
LalibertéL, VilleneuveJP. (1996) Hepatitis after the use of germander. A herbal remedy. Canadian Medical Association Journal, 154, 1689–1692.
66.
Perez AlvarezJ, Sáez-RoyuelaF, Gento PeñaE, López MoranteA, Velasco OsésA, Martin LorenteJ. (2001) Acute hepatitis due to ingestion of Teucrium chamaedrys infusions. Gastroenterologiay Hepatologia, 24, 240–243.
67.
LoeperJ, DescatoireV, LetteronP, MoulisC, DegottC, DansetteP, FauD, PessayreD. (1994) Hepatotoxicity of germander in mice. Gastroenterology, 106, 464–472.
68.
KambojA, SalujaAK. (2010) Phytopharmacological review of Xanthium strumarium L. (Cocklebur). International Journal of Green Pharmacy, 4, 129–139.
69.
WangY, HanT, XueLM, HanP, ZhangQY, HuangBK, ZhangH, MingQL, PengW, QinLP. (2011) Hepatotoxicity of kaurene glycosides from Xanthium strumarium L. fruits in mice. Pharmazie, 66, 445–449.
70.
TurgutM, AlhanCC, GürgözeM, KurtA, DoğanY, TekatliM, AkpolatN, AygiinAD. (2005) Carboxyatractyloside poisoning in humans. Annals of Tropical Paediatrics, 25, 125–134.
71.
MofidiM, SaidiH. (2009) Toxic effect of Xanthium strumarium as an herbal medicine preparation. EXCLIJournal, 8, 115–117.
CircuML, AwTY. (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Biology and Medicine, 48, 749–762.
76.
Wong-ekkabutJ, XuZ, TriampoW, TangIM, MonticelliDP. (2007) Effect of lipid peroxidation on the properties of lipid bilayers: A molecular dynamics study. Biophysiology Journal, 93, 4225–4236.
77.
SaidinNA. (2008) Cytotoxicity of extract of Malaysian Mitragyna speciosa Korth and its dominant alkaloid mitragynine (Doctoral dissertation, Imperial College London).
78.
LekehalM, PessayreD, LereauJM, MoulisC, FourasteI, FauD. (1996) Hepatotoxicity of the herbal medicine germander: Metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology, 24, 212–218.
79.
KaplowitzN. (1997) Hepatotoxicity of herbal remedies: insights into the intricacies of plant-animal warfare and cell death. Gastroenterology, 113, 1408–1412.
TsujimotoY, ShimizuS. (2007) Role of the mitochondrial membrane permeability transition in cell death. Apoptosis, 12, 835–840.
83.
GurfinkelDM, ChowS, HurrenR, GrondaM, HendersonC, BerubeC, HedleyDW, SchimmerAD. (2006) Disruption of the endoplasmic reticulum and increases in cytoplasmic calcium are early events in cell death induced by the natural triterpenoid asiatic acid. Apoptosis, 11, 1463–1471.
84.
LeeYS, JinDQ, KwonEJ, ParkSH, LeeES, JeongTC, NamDH, HuhK, KimJA. (2002) Asiatic acid, a triterpene, induces apoptosis through intracellular Ca2+ release and enhanced expression of p53 in HepG2 human hepatoma cells. Cancer Letters, 186, 83–91.
85.
ChengJS, JanCR. (2002). Effect of nordihydroguaiaretic acid on intracellular Ca2+ concentrations in hepatocytes. Toxicology in vitro, 16, 485–490.
86.
KochGL. (1990) The endoplasmic reticulum and calcium storage. Bioessays, 12, 527–531.
87.
ChiangJH, YangJS, MaCY, YangMD, HuangHY, HsiaTC, KuoHM, WuPP, LeeTH, ChungJG. (2011) Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways. Chemical Research in Toxicology, 24, 20–29.
88.
FujiwaraT, TakamiN, MisumiY, IkeharaY. (1998) Nordihydroguaiaretic acid blocks protein transport in the secretory pathway causing redistribution of Golgi proteins into the endoplasmic reticulum. The Journal of Biological Chemistry, 273, 3068–3075.
89.
RobertsMF, WinkM. (1998) Alkaloid biochemistry, ecology and medicinal application. Springer Science & Business Media, New York, 301–326.
90.
SturgillMG, LambertGH. (1997) Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function. Clinical Chemistry, 43, 1512–1526.
91.
BoosKS, SchlimmeE. (1981) Anthraquinone dyes: anew class of potent inhibitors of mitochondria adenine nucleotide translocation and oxidative phosphorylation. FEBSLetters, 27, 40–44.
92.
MattocksAR, WhiteIN. (1971) The conversion of pyrrolizidine alkaloids to W-oxides and to dihydropyrrolizine derivatives by rat-liver microsomes in vitro. Chemico- Biological Interaction, 3, 383–396.
93.
MattocksAR. (1972) Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolizidine alkaloids. Chemico- Biological Interaction, 5, 227–242.
94.
BoyerTD, MannsMP, SanyalAJ. (2012) Zakim and Boyer's hepatology: a textbook of liver disease, 6 ed. Elsevier Saunders, Philadelphia415–493.
95.
FarrellLD, KakarS. (2011) Liver Pathology Vol. 4, Demos Medical Publishing, New York, 1–273.
96.
KrenkelO, MossanenJC, TackeF. (2014) Immune mechanisms in acetaminophen-induced acute liver failure. Hepatobiliary Surgery Nutrition, 3, 331–343.
MadsenDH, JiirgensenHJ, IngvarsenS, MelanderMC, VainerB, EgerodKL, HaldA, RønøB, MadsenCA, BuggeTH, EngelholmLH, BehrendtN. (2012) Endocytic collagen degradation: a novel mechanism involved in protection against liver fibrosis. Journal of Pathology, 227, 94–105.
99.
GressnerAM, WeiskirchenR. (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. Journal of Cellular Molecular Medicine, 10, 76–99.
100.
PughN, RossSA, ElSohlyMA, PascoDS. (2001). Characterization of aloeride, a new high-molecular-weight polysaccharide from Aloe vera with potent immunostimulatory activity. Journal of Agricultural and Food Chemistry, 49, 1030–1034.
101.
CohenSM, O'ConnorAM, HartJ, MerelNH, TeHS. (2004) Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause, 11, 575–577.85.
